Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia

Starting soon · Not applicable

Conditions studied: Hormone Receptor Positive Breast Carcinoma, Postmenopausal, Breast Cancer

In brief

The objective of the pilot RCT is to evaluate the feasibility and acceptability of a Tai Chi intervention "TaiChi4Joint" vs. an HE AC group for relieving AIIA in women with hormone receptor positive stage I-III BCa. The investigators will pilot test our data collection for mechanism measures via three innovatively integrated biobehavioral pathways.

Key facts

Study ID

NCT07737951

Run by

Thomas Jefferson University

People needed

40

Starts

2026-06-01

Expected to finish

2029-06-01

Last updated by the study team

2026-07-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Individuals must meet all the following inclusion criteria in order to be eligible to participate in the study:
• Age ≥18 years
• Diagnosis of stage I-III hormone receptor-positive breast cancer
• Postmenopausal
• Currently receiving an aromatase inhibitor (anastrozole, letrozole, or exemestane) or within 5 years of initiation
• Report joint pain that started or worsened after initiation of AI therapy
• Report worst pain in the past week ≥3 on the BPI (0-10 scale)
• Able to complete study procedures in English
• Willing to be randomized to an intervention or attention control group and adhere to study procedures

You may not qualify if…

• An individual who meets any of the following criteria will be excluded from participation in this study:
• Undergoing active cancer treatment (excluding endocrine therapy)
• Uncontrolled cardiac or pulmonary disease that would limit safe participation
• Currently engaged in regular structured moderate- or vigorous-intensity exercise (e.g., brisk walking, jogging/running, cycling, swimming, aerobic classes, or resistance training) totaling ≥150 minutes per week over the past 3 months
• Currently participating in Tai Chi, yoga, Pilates, or other structured mind-body practice ≥2 times per week over the past 3 months
• Joint pain due to inflammatory arthritic conditions
• Recent surgery or joint injection within the past 4-6 weeks
• Initiation or dose change of corticosteroids or opioids within the past 4 weeks
• Planned discontinuation of AI therapy within the next 6 months
• This study is limited to women with breast cancer, as <1% of cases occur in men and data on AIIA in male patients are limited

Where it is running

• Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.